The Role of Radionuclide Imaging in Epilepsy, Part 1: Sporadic Temporal and Extratemporal Lobe Epilepsy
暂无分享,去创建一个
[1] D J Brooks,et al. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.
[2] W H Theodore,et al. Antiepileptic Drugs and Cerebral Glucose Metabolism , 1988, Epilepsia.
[3] D. Ingvar,et al. Regional cerebral blood flow in focal cortical epilepsy. , 1976, Archives of neurology.
[4] B. Spännare,et al. In Vitro Quantitative Autoradiography of [3H]‐L‐Deprenyl and [3H]‐PK 11195 Binding Sites in Human Epileptic Hippocampus , 1992, Epilepsia.
[5] O Muzik,et al. Objective method for localization of cortical asymmetries using positron emission tomography to aid surgical resection of epileptic foci. , 1998, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.
[6] Laurent Spelle,et al. Insular cortex involvement in mesiotemporal lobe epilepsy: A positron emission tomography study , 2002, Annals of neurology.
[7] C. Rowe,et al. Patterns of postictal cerebral blood flow in temporal lobe epilepsy , 1991, Neurology.
[8] K. Byth,et al. The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG‐PET , 2010, Epilepsia.
[9] Karl J. Friston,et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. , 1996, Brain : a journal of neurology.
[10] D. Prince,et al. Control mechanisms in cortical epileptogenic foci. "Surround" inhibition. , 1967, Archives of neurology.
[11] Bengt Långström,et al. NMDA‐Receptor Activity Visualized with (S)‐[N‐Methyl‐11C]Ketamine and Positron Emission Tomography in Patients with Medial Temporal Lobe Epilepsy , 1999, Epilepsia.
[12] S. Sato,et al. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy , 1995, Neurology.
[13] A. Alavi,et al. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] J. Mazziotta,et al. Interictal metabolic anatomy of mesial temporal lobe epilepsy. , 1993, Archives of neurology.
[15] D. Brooks,et al. Focal cortical release of endogenous opioids during reading induced seizures , 1998, The Lancet.
[16] H. Chugani,et al. α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies. , 2011, Biomarkers in medicine.
[17] Alan A. Wilson,et al. Quantification of mu and non–mu opiate receptors in temporal lobe epilepsy using positron emission tomography , 1991, Annals of neurology.
[18] Markus Piel,et al. Decreased Dopamine D2/D3‐Receptor Binding in Temporal Lobe Epilepsy: An [18F]Fallypride PET Study , 2006, Epilepsia.
[19] I. Scheffer,et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy , 2008, Neurology.
[20] Conrad V. Kufta,et al. Temporal lobectomy for uncontrolled seizures: The role of positron emission tomography , 1992, Annals of neurology.
[21] M. Newton,et al. Ictal SPECT and Interictal PET in the Localization of Occipital Lobe Epilepsy , 2000, Epilepsia.
[22] A. Khonsari,et al. Improved Sensitivity of 18FDG‐Positron Emission Tomography Scans in Frontal and “Frontal Plus” Epilepsy , 1995, Epilepsia.
[23] Alan A. Wilson,et al. Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy , 1988, Annals of neurology.
[24] B. Brinkmann,et al. Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome , 2000, Neurology.
[25] H G Wieser,et al. Mesiobasal versus lateral temporal lobe epilepsy , 1993, Neurology.
[26] S. Berkovic,et al. Ictal 99mTc‐HMPAO Single Photon Emission Computed Tomography in Children with Temporal Lobe Epilepsy , 1993, Epilepsia.
[27] Dong Soo Lee,et al. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] G. Fein,et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy , 1997, Annals of neurology.
[29] D. Lee,et al. Diagnostic Performance of [18F]FDG‐PET and Ictal [99mTc]‐HMPAO SPECT in Occipital Lobe Epilepsy , 2001, Epilepsia.
[30] Bertrand Devaux,et al. Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study. , 2004, Brain : a journal of neurology.
[31] A. Alavi,et al. Predictors of outcome after anterior temporal lobectomy , 1994, Neurology.
[32] Jean-Claude Baron,et al. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons , 2003, NeuroImage.
[33] D E Kuhl,et al. In vivo cerebral metabolism and central benzodiazepine‐receptor binding in temporal lobe epilepsy , 1993, Neurology.
[34] L. Borgwardt,et al. Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. , 2007, Seminars in nuclear medicine.
[35] Otto Muzik,et al. Objective Detection of Epileptic Foci by 18F-FDG PET in Children Undergoing Epilepsy Surgery , 2010, The Journal of Nuclear Medicine.
[36] Otto Muzik,et al. Identification of Frontal Lobe Epileptic Foci in Children Using Positron Emission Tomography , 1997, Epilepsia.
[37] D J Brooks,et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. , 2002, Brain : a journal of neurology.
[38] Al Bartolucci,et al. Functional imaging: II. Prediction of epilepsy surgery outcome , 2008, Annals of neurology.
[39] David C. Reutens,et al. Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[40] Ivanka Savic,et al. [11C]Flumazenil Positron Emission Tomography Visualizes Frontal Epileptogenic Regions , 1995, Epilepsia.
[41] O Muzik,et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy , 2000, Neurology.
[42] I Savic,et al. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[43] Karel G M Moons,et al. Prognosis after temporal lobe epilepsy surgery: The value of combining predictors , 2008, Epilepsia.
[44] S. Weinstein,et al. Low incidence of abnormal 18FDG-PET in children with new-onset partial epilepsy: A prospective study , 2002, Neurology.
[45] Jae Sung Lee,et al. Diagnostic performance of 18F-FDG PET and ictal 99mTc-HMPAO SPET in pediatric temporal lobe epilepsy: Quantitative analysis by statistical parametric mapping, statistical probabilistic anatomical map, and subtraction ictal SPET , 2005, Seizure.
[46] T. Yousry,et al. Ictal ECD-SPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control , 2001, Nuclear medicine communications.
[47] Mijin Yun,et al. Relationship between bilateral temporal hypometabolism and EEG findings for mesial temporal lobe epilepsy: Analysis of 18F-FDG PET using SPM , 2006, Seizure.
[48] R. Wennberg,et al. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy A meta-analysis , 2007, Seizure.
[49] R. Kessler,et al. Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography. , 1996, Investigative radiology.
[50] B. Långström,et al. PET with 11C‐deuterium‐deprenyl and 18F‐FDG in focal epilepsy , 2001, Acta neurologica Scandinavica.
[51] A. Bye,et al. Application of statistical parametric mapping to SPET in the assessment of intractable childhood epilepsy , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[52] F. Leijten,et al. The Added Value of [18F]‐Fluoro‐D‐deoxyglucose Positron Emission Tomography in Screening for Temporal Lobe Epilepsy Surgery , 2007, Epilepsia.
[53] Tae Joo Jeon,et al. Evaluation of ictal brain SPET using statistical parametric mapping in temporal lobe epilepsy , 2000, European Journal of Nuclear Medicine.
[54] Kazuhiko Yanai,et al. Histamine H1 receptors in complex partial seizures , 1993, The Lancet.
[55] Neda Bernasconi,et al. α-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy , 2003, Neurology.
[56] Alexander Hammers,et al. Pharmacoresistance in Epilepsy : A Pilot PET Study with the P-Glycoprotein Substrate R-[ 11 C ] verapamil ∗ † , 2007 .
[57] M. Behen,et al. Bilateral Medial Prefrontal and Temporal Neocortical Hypometabolism in Children with Epilepsy and Aggression , 2001, Epilepsia.
[58] B H Brinkmann,et al. Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci , 1999, Neurology.
[59] P. Van Bogaert,et al. Statistical Parametric Mapping of Regional Glucose Metabolism in Mesial Temporal Lobe Epilepsy , 2000, NeuroImage.
[60] Karl J. Friston,et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. , 1997, Brain : a journal of neurology.
[61] C. Binnie,et al. Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy , 2000, Neurology.
[62] Conrad V. Kufta,et al. FDG‐Positron Emission Tomography and Invasive EEG: Seizure Focus Detection and Surgical Outcome , 1997, Epilepsia.
[63] O Muzik,et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome , 2001, Neurology.
[64] L. Rozhkov,et al. Multimodality imaging in the surgical treatment of children with nonlesional epilepsy , 2011, Neurology.
[65] I Gardin,et al. Use of subtraction ictal SPECT co-registered to MRI for optimizing the localization of seizure foci in children. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] O W Witte,et al. Prefrontal asymmetric interictal glucose hypometabolism and cognitive impairment in patients with temporal lobe epilepsy. , 1997, Brain : a journal of neurology.
[67] J C Froment,et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. , 1998, Brain : a journal of neurology.
[68] O. Muzik,et al. Longitudinal Changes in Cortical Glucose Hypometabolism in Children With Intractable Epilepsy , 2006, Journal of child neurology.
[69] O. Dulac,et al. Single-photon emission computed tomography: ictal perfusion in childhood epilepsies , 1999, Brain and Development.
[70] C. Jack,et al. Subtraction ictal SPECT co‐registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus , 1998, Neurology.
[71] J. Hirvonen,et al. Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy , 2012, The Journal of Nuclear Medicine.
[72] A. Hufnagel,et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. , 2006, Brain : a journal of neurology.
[73] O Delalande,et al. Ictal SPECT in children with epilepsy: comparison with intracranial EEG and relation to postsurgical outcome. , 2003, Brain : a journal of neurology.
[74] H. Chugani,et al. Clinical and histopathologic correlates of 11C‐alpha‐methyl‐l‐tryptophan (AMT) PET abnormalities in children with intractable epilepsy , 2011, Epilepsia.
[75] C. Chung,et al. Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia , 2009, Neurology.
[76] Dong Soo Lee,et al. Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.